Abstract
We report the largest pediatric multicenter experience with Impella pump use and peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. Utilizing the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) collaborative database, we conducted a retrospective, multicenter study of all patients with cardiogenic shock requiring VA-ECMO support with subsequent Impella implant between October 2014 and December 2021. The primary outcome was defined as death while on Impella support. Secondary outcomes were recovery, transplantation, and transition to durable ventricular assist device (VAD) at the time of Impella explantation. Adverse events were defined according to the ACTION registry criteria. Twenty subjects were supported with Impella; Impella 2.5 (n = 3), CP (n = 12), 5.0/5.5 (n = 5). The median Interquartile range (IQR) age, weight, and body surface area at implantation were 15.6 years (IQR = 13.9–17.2), 65.7 kg (IQR = 53.1–80.7), and 1.74 m2 (IQR = 1.58–1.98). Primary cardiac diagnoses were dilated cardiomyopathy/myocarditis in nine (45%), congenital heart disease in four (20%), graft failure/rejection in four (20%), and three (15%) others. Most common adverse events included hemolysis (50%) and bleeding (20%). There were two deaths (10%) in the cohort. Nine patients (45%) were explanted for recovery, eight (40%) were transitioned to a durable VAD, and one (5%) underwent heart transplantation. Impella percutaneous pump support should be considered in the older pediatric population supported with peripheral VA-ECMO, as a means of left heart decompression, and a strategy to come off ECMO to achieve endpoints of myocardial recovery, transition to a durable VAD, or transplantation.
This ACTION study was published in ASAIO Journal on February 5, 2024. Congratulations to the authors:
- Svetlana B. Shugh
- Sebastian C. Tume
- Neha Bansal
- John C. Dykes
- Jesse J. Esch
- Aamir Jeewa
- Sabrina Law
- Matthew O’Connor
- John J. Parent
- Ahmed S. Said
- Frank G. Scholl
- Muhammad F. Shezad
- Brian H. Murray
- +ACTION Investigators
CITATION
Shugh, Svetlana B.; Tume, Sebastian C.; Bansal, Neha; Dykes, John C.; Esch, Jesse J.; Jeewa, Aamir; Law, Sabrina; O’Connor, Matthew; Parent, John J.; Said, Ahmed S.; Scholl, Frank G.; Shezad, Muhammad F.; Morray, Brian H.; on Behalf of ACTION Investigators. Transcatheter Axial Pump Use in Pediatric Patients on Veno-Arterial Extracorporeal Membrane Oxygenation: An ACTION Collaborative Experience. ASAIO Journal ():10.1097/MAT.0000000000002150, February 05, 2024. | DOI: 10.1097/MAT.0000000000002150
